Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.33 USD
+0.28 (1.40%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $20.33 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth B Momentum A VGM
Price, Consensus and EPS Surprise
FMS 20.33 +0.28(1.40%)
Will FMS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FMS
Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Here's Why Fresenius (FMS) is a Strong Value Stock
Other News for FMS
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from UBS
Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Highlights: Strong Margin Growth and ...
Fresenius Medical Care AG 2024 Q3 - Results - Earnings Call Presentation
Fresenius Medical Care Reports Strong Q3 2024 Results
Fresenius Medical Care Unveils New Long-Term Incentive Plan